Navigation Links
MDdatacor Designated as Approved Vendor by CMS for Physician Quality Reporting Initiative
Date:8/27/2008

ATLANTA, Aug. 27 /PRNewswire/ -- MDdatacor, Inc., a leader in health care quality management solutions for health plans and providers, announced today that CMS has approved the company as a vendor for the Centers for Medicare & Medicaid Services (CMS).

MDdatacor will automate the collection and submission of clinical information for CMS, relieving the administrative burden of having to hand-write data collection worksheets or manually enter data into a registry system. MDdatacor's patented and interoperable CareInformatix(TM) technology collects clinical data from physician practices' existing electronic medical record, practice management, lab and registry systems, regardless of vendor, as well as from transcribed notes.

Specifically, MDdatacor will submit quality measures data on behalf of providers to CMS as part of the organization's Physician Quality Reporting Initiative (PQRI) for 2008. PQRI is a voluntary pay-for-reporting program designed to improve the quality of patient care provided to Medicare beneficiaries. The program provides payment of up to 1.5% of the total allowed charges for covered Medicare physician fee schedule services to eligible healthcare professionals who successfully report PQRI quality measures.

"MDdatacor has a proven track record of providing physicians with tools that improve patient care while helping them achieve financial rewards for delivering high-quality, evidence-based care," said Tim Roche, co-founder, president and chief executive officer of MDdatacor. "The selection of MDdatacor as an approved CMS vendor demonstrates a viable alternative to using just claims data or manually collecting clinical data for PQRI reporting, even within organizations using disparate IT systems."

About MDdatacor

Established in 2001 and headquartered in Atlanta, Georgia, MDdatacor enhances healthcare quality through the development of innovative technology solutions. MDdatacor solutions are used to support quality improvement, health information exchange and Patient-Centered Medical Home initiatives. MDdatacor currently serves more than 7,000 physicians representing more than seven million patients. For more information, visit http://www.mddatacor.com or call (866) 460-5681.

Contact:

Heather McLarney

(866) 460-5681

Heather.mclarney@mddatacor.com


'/>"/>
SOURCE MDdatacor, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. STAAR Surgicals Collamer(R) IOL Designated as a New Technology Intraocular Lens by the Centers for Medicare and Medicaid Services
2. China Aoxing Pharmaceutical Designated as a Key Manufacturer of Cancer Pain Drug by China SFDA
3. Zemea Propanediol Approved as a Natural Ingredient by ECOCERT
4. CardioWest™ Artificial Heart Approved For Highest Reimbursement in CMS History : Plus Up To $53,000 New Technology Add-on Payments
5. Biopten (Sapropterin Dihydrochloride) Approved by Japanese Ministry of Health for the Treatment of PKU
6. TriCipher is First to Transfer Smart Card Level Security to Federally Approved SAFE-BioPharma(TM) Roaming Credentials
7. New Aptivus(R) (tipranavir) Oral Solution Approved for Treatment-Experienced Pediatric and Adolescent HIV Patients
8. Stallergenes : Sublingual Desensitisation Tablets Oralair Grasses Approved in Germany
9. Pharmaceutical Competitive Intelligence Excellence: Optimizing Data Collection with Approved Guidelines
10. Revolutionary Healing Technology for Treating Difficult and Chronic Wounds Approved by Health Canada
11. CryoLife to Distribute FDA-approved Hemostatic Agent Under Private Label
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... Research and Markets has announced the addition of the ... ... provides separate comprehensive analytics for the US, Japan ... estimates and forecasts are provided for the period 2015 through 2022. ... data and analytics are derived from primary and secondary research. This ...
(Date:2/17/2017)... , Feb. 17, 2017  Protagonist Therapeutics, ... data on its oral peptide drug candidates, PTG-100 ... of the European Crohn,s and Colitis Organization (ECCO).  ... Barcelona, Spain from February 15 ... detail preclinical data on Protagonist drug candidates PTG-100 ...
(Date:2/16/2017)... , Feb. 16, 2017  MDNA Life Sciences ... development of liquid biopsy tests based on the ... an exclusive license agreement with its first international ... liquid biopsy test for prostate cancer, the Prostate ... . This is the first overseas appointment ...
(Date:2/16/2017)... BEACH, Florida , February 16, 2017 /PRNewswire/ ... improving with the infusion of innovative telemedicine application, ... monitoring services that are experiencing a boom worldwide. ... with the advancement of technologies, services and new ... Inc. (OTC: RQHTF) (TSX-V: RHT), Cellectar Biosciences, Inc. ...
Breaking Biology Technology:
(Date:2/8/2017)... YORK , Feb. 7, 2017 Report Highlights ... The ... should reach $11.4 billion by 2021, growing at a compound ... Includes - An overview of the global markets for synthetic ... 2015, estimates for 2016, and projections of compound annual growth ...
(Date:2/7/2017)... 7, 2017   MedNet Solutions , an innovative ... of clinical research, is pleased to announce that the ... innovative, highly flexible and award winning eClinical solution, is ... iMedNet is a proven Software-as-a-Service (SaaS) clinical research ... (EDC), but also delivers an entire suite of eClinical ...
(Date:2/6/2017)... 2017 According to Acuity Market Intelligence, ... authorities to continue to embrace biometric and digital ... Automated Border Control (ABC) eGates and 1436 Automated ... than 163 ports of entry across the globe. ... a combined CAGR of 37%. APC Kiosks reached ...
Breaking Biology News(10 mins):